The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III study of sintilimab in combination with modified folfrinox versus folfrinox alone in patients with metastatic and recurrent pancreatic cancer in China: The CISPD3 trial.
 
Qihan Fu
No Relationships to Disclose
 
Yiwen Chen
No Relationships to Disclose
 
Dabing Huang
No Relationships to Disclose
 
Chengxiang Guo
No Relationships to Disclose
 
Qi Zhang
No Relationships to Disclose
 
Xiang Li
No Relationships to Disclose
 
Xiaochen Zhang
No Relationships to Disclose
 
Shunliang Gao
No Relationships to Disclose
 
Risheng Que
No Relationships to Disclose
 
Yan Shen
No Relationships to Disclose
 
Jian Wu
No Relationships to Disclose
 
Min Zhang
No Relationships to Disclose
 
Xueli Bai
No Relationships to Disclose
 
Tingbo Liang
No Relationships to Disclose